Selasie Goka1,2, Lawrence Copelovitch1,2, Daniella Levy Erez3,4. 1. Nephrology Division, Children's Hospital of Philadelphia, 34th Street and Civic Center Blvd, Philadelphia, PA, 19004, USA. 2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 3. Nephrology Division, Children's Hospital of Philadelphia, 34th Street and Civic Center Blvd, Philadelphia, PA, 19004, USA. levyerezd@email.chop.edu. 4. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. levyerezd@email.chop.edu.
Abstract
BACKGROUND: Alport syndrome (AS) is a multisystem condition which can result in progressive kidney disease, hearing loss, and ocular changes. X-linked inheritance is observed in 85% of affected individuals. As a result, most prior studies have focused on males. Girls with AS can also be symptomatic although historically thought to have few clinical manifestations in childhood. The objective of the study was to describe the clinical presentation and course of females with AS. METHODS: A single-center retrospective study of all young females with AS between January 1, 1987, and May 20, 2019. Subjects were identified using ICD-9/10 diagnosis codes for AS, familial hematuria, or nephritis. Clinical data were extracted by retrospective chart review. RESULTS: Thirty-six female patients were included in the analysis. Mean age at presentation was 5.58 ± 3.0 years, and mean follow-up was 5.9 ± 3.9 years. Twenty-nine patients (80%) had a family history of AS. At end of the follow-up period, gross hematuria was observed in 15 patients (42%), 20 (56%) developed proteinuria, and 2 (6.7%) had an estimated glomerular filtration rate (eGFR) < 90 ml/min/1.73m2 with one patient developing stage 5 chronic kidney disease. Four of the twenty-seven (14.8%) who underwent audiologic testing had an abnormal exam. CONCLUSIONS: Known family histories of AS or gross hematuria were the most common reasons for the initial presentation in our cohort. Development of proteinuria, eGFR < 90 ml/min/1.73m2, and abnormal audiology exam are not exceptional findings, suggesting that close monitoring of young females into adulthood is warranted.
BACKGROUND: Alport syndrome (AS) is a multisystem condition which can result in progressive kidney disease, hearing loss, and ocular changes. X-linked inheritance is observed in 85% of affected individuals. As a result, most prior studies have focused on males. Girls with AS can also be symptomatic although historically thought to have few clinical manifestations in childhood. The objective of the study was to describe the clinical presentation and course of females with AS. METHODS: A single-center retrospective study of all young females with AS between January 1, 1987, and May 20, 2019. Subjects were identified using ICD-9/10 diagnosis codes for AS, familial hematuria, or nephritis. Clinical data were extracted by retrospective chart review. RESULTS: Thirty-six female patients were included in the analysis. Mean age at presentation was 5.58 ± 3.0 years, and mean follow-up was 5.9 ± 3.9 years. Twenty-nine patients (80%) had a family history of AS. At end of the follow-up period, gross hematuria was observed in 15 patients (42%), 20 (56%) developed proteinuria, and 2 (6.7%) had an estimated glomerular filtration rate (eGFR) < 90 ml/min/1.73m2 with one patient developing stage 5 chronic kidney disease. Four of the twenty-seven (14.8%) who underwent audiologic testing had an abnormal exam. CONCLUSIONS: Known family histories of AS or gross hematuria were the most common reasons for the initial presentation in our cohort. Development of proteinuria, eGFR < 90 ml/min/1.73m2, and abnormal audiology exam are not exceptional findings, suggesting that close monitoring of young females into adulthood is warranted.
Authors: Michelle N Rheault; Stefan M Kren; Linda A Hartich; Melanie Wall; William Thomas; Hector A Mesa; Philip Avner; George E Lees; Clifford E Kashtan; Yoav Segal Journal: Nephrol Dial Transplant Date: 2009-10-23 Impact factor: 5.992
Authors: Moumita Barua; Rohan John; Lorenzo Stella; Weili Li; Nicole M Roslin; Bedra Sharif; Saidah Hack; Ginette Lajoie-Starkell; Andrew L Schwaderer; Brian Becknell; Matthias Wuttke; Anna Köttgen; Daniel Cattran; Andrew D Paterson; York Pei Journal: Am J Kidney Dis Date: 2017-12-01 Impact factor: 8.860
Authors: Oliver Gross; Clifford E Kashtan; Michelle N Rheault; Frances Flinter; Judith Savige; Jeffrey H Miner; Roser Torra; Elisabet Ars; Constantinos Deltas; Isavella Savva; Laura Perin; Alessandra Renieri; Francesca Ariani; Francesca Mari; Colin Baigent; Parminder Judge; Bertrand Knebelman; Laurence Heidet; Sharon Lagas; Dave Blatt; Jie Ding; Yanqin Zhang; Daniel P Gale; Marco Prunotto; Yong Xue; Asher D Schachter; Lori C G Morton; Jacqui Blem; Michael Huang; Shiguang Liu; Sebastien Vallee; Daniel Renault; Julia Schifter; Jules Skelding; Susie Gear; Tim Friede; A Neil Turner; Rachel Lennon Journal: Nephrol Dial Transplant Date: 2017-06-01 Impact factor: 5.992
Authors: Ana Marta Gomes; Daniela Lopes; Clara Almeida; Sofia Santos; Jorge Malheiro; Irina Lousa; Alberto Caldas Afonso; Idalina Beirão Journal: Int J Mol Sci Date: 2022-06-30 Impact factor: 6.208